Methacrylic Acid

Methacrylic Acid

SCHEMBL1998337

C=C(C)C(=O)O.CCCC.O=S(=O)(O)O

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Methacrylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.35
TSHR P16473 2/20 0.34
TGFBR1 P36897 1/20 0.34
FFAR3 O14843 3/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
TP53 P04637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALDH1A1 P00352 2/20 0.32
CA5A P35218 1/20 0.32
CA5B Q9Y2D0 1/20 0.32
THRB P10828 2/20 0.31
FNTA P49354 1/20 0.31
FNTB P49356 1/20 0.31
PGGT1B P53609 1/20 0.31
ALOX15 P16050 1/20 0.30
LCK P06239 1/20 0.30
FYN P06241 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL22325631 0.90 TGFBR1 (0.36) TDP1TSHRTGFBR1FFAR3HDAC3
Methacrylic Acid SCHEMBL999438 0.89 TDP1 (0.42) TDP1TSHRTGFBR1FFAR3HSD17B10
Methacrylic Acid SCHEMBL3124718 0.89 TDP1 (0.42) TDP1TSHRTGFBR1FFAR3HDAC3
Methacrylic Acid SCHEMBL29038212 0.89 TDP1 (0.42) TDP1TSHRTGFBR1FFAR3HDAC3
Methacrylic Acid SCHEMBL570136 0.89 TDP1 (0.42) TDP1TSHRTGFBR1FFAR3HDAC3
Methacrylic Acid SCHEMBL6862647 0.89 TDP1 (0.42) TDP1TSHRTGFBR1FFAR3HSD17B10
Methacrylic Acid SCHEMBL9632125 0.89 TDP1 (0.42) TDP1TSHRTGFBR1FFAR3HDAC3
Methacrylic Acid SCHEMBL224237 0.86 TDP1 (0.36) TDP1TSHRTGFBR1FFAR3ALDH1A1
Methacrylic Acid SCHEMBL22493124 0.86 TDP1 (0.40) TDP1TSHRTGFBR1FFAR3HSD17B10
Methacrylic Acid SCHEMBL11177420 0.86 TDP1 (0.40) TDP1TSHRTGFBR1FFAR3HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2555747-B1 A COMBINATION OF CROSSLINKED CATIONIC POLYMER AND AMPHOLYTIC POLYMER FOR PERSONAL AND HOUSEHOLD APPLICATIONS LUBRIZOL ADVANCED MAT INC (US) 2017-02-22 EP claimed
US-7964545-B2 Skin cleansing composition KAO CORPORATION (JP) 2011-06-21 US disclosed
US-20090286707-A1 SKIN CLEANSING COMPOSITION KAO CORPORATION (JP) 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286707-A1 SKIN CLEANSING COMPOSITION DEGS1, SGMS1, SPTAN1 TDP1 1826/4885TSHR 4875/4885TGFBR1 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.